Skip to main content

Innosuisse — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

213
Companies
$612.7M
Total invested
$2.9M
Avg. check
57
Industries
Artificial Intelligence (AI) 6Biotechnology 5Software 5Health Care 5Manufacturing 4Life Science 3+51 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 213
FluoSphera
January 2026

FluoSphera is a developer of drugs.

Biotechnology · Geneva$1.4M Seed
Raven Intelligent Systems
January 2026

End-to-end automated work-safety inspections for high-risk sites

Artificial Intelligence (AI) · Ecublens$126K Grant
kuafu
January 2026

kuafu is committed to accelerating grid decarbonization and driving the energy transition to net zero.

Artificial Intelligence (AI) · DubendorfGrant
Lighthouse Tech
December 2025

Lighthouse Tech created TAMI®, the first smart eyewear merging obstacle detection with fashion for global mobility markets.

Eyewear · Morbio Inferiore$1.5M Grant
Swisspod
November 2025

Swisspod is a technology company that develops energy-efficient hyperloop systems that specializes in high speed transportation solutions.

Energy · Monthey$13.0M Seed
Vestir AI
October 2025

Vestir AI is a B2B fashion tech company offering virtual fitting room technology combining 3D computer vision with GenAI

3D Technology · ZugAngel
Multiwave Technologies
September 2025

Multiwave is a deep tech company developing disruptive medical imaging devices

Advanced Materials · Geneva$4.5M Venture - Series Unknown
Veezoo
September 2025

Veezoo is a software company that develops analytics solution for business insights from cloud databases using natural-language.

Analytics · Zürich$6.0M Series A
Cutiss
September 2025

Cutiss is a life science company that engages in regenerative medicine production, skin tissue engineering, and curated therapy solutions.

Beauty · Zürich$38.9M Series C
Cellvie
September 2025

Cellvie develops cell-derived medicines, leveraging the therapeutic potential of mitochondria, the powerhouses of the cell.

Biotechnology · Houston$5.0M Seed
Calvin Risk
September 2025

Calvin Risk develops comprehensive and quantitative solutions to assess and manage the risks of AI algorithms in commercial use.

Artificial Intelligence (AI) · KlotenGrant
REOR20
September 2025

SaaS, pre-event high fidelity flood risk assessment, post-event accurate flood analysis

Insurance · ZürichGrant
Oxara
September 2025

Oxara is a construction technology company that manufactures low carbon, circular, and healthy building materials for real estate projects.

Association · DietikonGrant
Fabas
September 2025

Fabas is an e-commerce website that offers food products like hummus, bean burgers, and falafel made from locally grown Swiss legumes.

E-Commerce · SchlierenGrant
qCella
September 2025

qCella Impregnate natural fibers with copper and utilize them to create heating mats that outperform commercially available heating wires.

Manufacturing · ZürichGrant
INERGIO
September 2025

INERGIO is a reliable power power supply yet is a challenge to off-grid systems.

Environmental Consulting · LausanneGrant
Apheros
September 2025

Apheros is a metal foam cooling solutions company that offers a patent-pending easily scalable manufacturing approach for metal foams.

3D Printing · ZürichGrant
HeroSupport
September 2025

HeroSupport transforms imaging and/or treatment tables into personalized solutions.

Health Care · VeyrierGrant
Planeto
September 2025

Planeto is an energy transition company that engages in the design of sustainable district heating and cooling networks in buildings.

Energy · Plan-les-ouatesGrant
Hemetron
September 2025

Hemetron offers a handheld blood testing device that measures biomarkers for at‑home health monitoring and remote result sharing.

Health Care · ZürichGrant
EDWATEC
September 2025

EDWATEC is at the forefront of developing Erbium-doped photonic integrated circuits for optical amplification on-chip.

Optical Communication · LausanneGrant
csky.ai
September 2025

csky.ai specializes in using Edge AI technologies to enrich even the most sensitive discussions.

Artificial Intelligence (AI) · PrillyGrant
Mabylon
August 2025

Mabylon develops novel antibody therapeutics in immunology & inflammation (I&I) and neurological disorders.

Biotechnology · Schlieren$18.6M Undisclosed
Azure Cell Therapies
July 2025

Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases

Biopharma · Geneva$189K Grant

Where Innosuisse invests

Artificial Intelligence (AI)6
Biotechnology5
Software5
Health Care5
Manufacturing4
Life Science3

About Innosuisse's portfolio

How many companies has Innosuisse invested in?▸

Innosuisse has invested in 213 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Innosuisse invest in?▸

Innosuisse's top investment sectors include Artificial Intelligence (AI), Biotechnology, Software, Health Care, Manufacturing. The firm invests across 57 different industry categories.

What is Innosuisse's largest investment?▸

Among tracked funding rounds, Cutiss received $38.9M in a Series C round. Innosuisse's total known invested capital is $612.7M.

What is the average investment size for Innosuisse?▸

Innosuisse's average investment size is $2.9M across its portfolio of 213 companies.

What are Innosuisse's most recent investments?▸

Recent Innosuisse portfolio additions include FluoSphera, Raven Intelligent Systems, kuafu, Lighthouse Tech, Swisspod. These companies were founded in 2020 or later.

Reach the founders behind these 213 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →